Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Peking Union Medical College Hospital: Clinical Trials & FDA Approval Profile

Peking Union Medical College Hospital (Global / Institutional) sponsors 250 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 99 active protocols (57 recruiting now), 22 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)4.8%
Median Closed Enrollment vs National (145 pts)33 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Peking Union Medical College Hospital
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)250
Active Pipeline (Recruiting Now)99 (57)
Completed vs Stopped Early22 / 12 (4.8%)
Median Closed Actual Enrollment33 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Peking Union Medical College Hospital
Hospital Research SiteLocationShared Protocols
Peking Union Medical College HospitalBeijing, Beijing Municipality158
Beijing HospitalBeijing, Beijing Municipality3
Peking University First HospitalBeijing, Beijing Municipality2

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Peking Union Medical College Hospital
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT06037889Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)Phase IIICOMPLETED

Explore interactive annual charts and M&A subsidiary rollups in the Peking Union Medical College Hospital Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI